United States Hemophilia B Market & Competitive Landscape, 2019 - Analysis on the Pipeline, Epidemiology, Market Valuations, and Drugs (Sales & Market Share) - ResearchAndMarkets.com

DUBLIN--()--The "US Hemophilia B Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

This latest research provides comprehensive insights into Haemophilia B pipeline products, Haemophilia B epidemiology, Haemophilia B market valuations and forecast, Haemophilia B drugs sales and competitive landscape in the US.

The research is classified into seven sections - Haemophilia B treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Haemophilia B pipeline: Find out the products in clinical trials for the treatment of Haemophilia B by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Haemophilia B epidemiology: Find out the number of patients diagnosed (prevalence) with Haemophilia B in the US
  • Haemophilia B drugs: Identify key products marketed and prescribed for Haemophilia B in the US, including trade name, molecule name, and company
  • Haemophilia B drugs sales: Find out the sales revenues of Haemophilia B drugs in the US
  • Haemophilia B market valuations: Find out the market size for Haemophilia B drugs in 2018 in the US. Find out how the market advanced from 2014 and forecast to 2024
  • Haemophilia B drugs market share: Find out the market shares for key Haemophilia B drugs in the US

This research helps executives to

  • Support monitoring and reporting national Haemophilia B market analysis and sales trends
  • Track competitor drugs sales and market share in the US Haemophilia B market
  • Track competitive developments in Haemophilia B market and present key issues and learnings
  • Synthesize insights for Haemophilia B market and products to drive business performance
  • Answer key business questions about the Haemophilia B market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Haemophilia B products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Haemophilia B Treatments

2) Haemophilia B Pipeline

3) US Haemophilia B Epidemiology

4) Marketed Drugs for Haemophilia B in US

5) US Haemophilia B Market Size and Forecast

6) US Haemophilia B Products Sales and Forecast

7) US Haemophilia B Market Competitive Landscape

8) Methodology

List of Tables

1. Haemophilia B Phase 3 Clinical Trials, 2019

2. Haemophilia B Phase 2 Clinical Trials, 2019

3. Haemophilia B Phase 1 Clinical Trials, 2019

4. Haemophilia B Epidemiology, US, 2014 - 2024

5. Marketed Drugs for Haemophilia B, US, 2018

6. Haemophilia B Market Size and Forecast ($), US, 2014 - 2024

7. Haemophilia B Product Sales ($), US, 2014 - 2024

List of Figures

1. Haemophilia B Epidemiology, US, 2014 - 2024

2. Haemophilia B Market Size and Forecast ($), US, 2014 - 2024

3. Haemophilia B Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/gdrsah

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs